J. Safra Sarasin Holding’s ResMed RMD Stock Holding History

J. Safra Sarasin Holding’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$354K	Buy	1,581 +16	+1%	+$3.99K	0.01%	459
2025 Q4	$377K	Sell	1,565 -10,794	-87%	-$2.76M	0.01%	435
2025 Q3	$3.38M	Buy	12,359 +5,001	+68%	+$1.37M	0.05%	169
2025 Q2	$1.9M	Sell	7,358 -2,608	-26%	-$622K	0.03%	228
2025 Q1	$2.23M	Sell	9,966 -582	-6%	-$136K	0.04%	209
2024 Q4	$2.41M	Sell	10,548 -1,470	-12%	-$354K	0.04%	208
2024 Q3	$2.93M	Sell	12,018 -376	-3%	-$84K	0.05%	177
2024 Q2	$2.37M	Buy	+12,394	New	+$2.51M	0.04%	213

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

J. Safra Sarasin Holding's RMD Position: Q1 2026 in Review

J. Safra Sarasin Holding increased its ResMed (RMD) stake by 1% in Q1 2026, buying an estimated $3.99K and bringing the position to 1,581 shares worth $354K. The position accounts for 0.01% of the portfolio, ranked #459.

J. Safra Sarasin Holding first reported a position in RMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.38M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

J. Safra Sarasin Holding held 1,581 shares of ResMed worth $354K as of Q1 2026.
J. Safra Sarasin Holding bought 16 ResMed shares in Q1 2026, an estimated $3.99K.
ResMed made up 0.01% of J. Safra Sarasin Holding's portfolio in Q1 2026, its #459 holding.
J. Safra Sarasin Holding first reported a position in ResMed in Q2 2024 and has held it in 8 quarters since.
J. Safra Sarasin Holding's ResMed position peaked at $3.38M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q1 2026, filed 4 May 2026.